Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07227519 · ClinicalTrials.gov registry record · NA

Effects of UPF Warning Labels on Social Media Among Teens and Young Adults

A NA study, sponsored by University of Tennessee.

Not yet
Registry status
NA
Development phase
1,000
Enrollment target

NCT07227519: Clinical Trial NA study, sponsored by University of Tennessee.

NCT07227519 is a NA study that has not yet begun recruiting, run by University of Tennessee. The registered enrollment target is 1,000 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07227519, a NA study, has not yet begun recruiting, sponsored by University of Tennessee.

NOT YET RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target

Study Summary

This study aims to evaluate whether Ultra-Processed Food (UPF) warning labels on social media posts improve consumer understanding and influence purchase intentions among teens and young adults. Participants aged 13-29 in the United States will be recruited and randomized into two groups: a control group (no label) and an intervention group (UPF warning). Participants will view social media posts featuring UPFs with or without warning labels and respond to survey questions following each post.

Primary Outcome

For each social media post, participants will be asked whether they think the product is ultra-processed. Response options will be "yes", "no", or "I don't know". Consumer understanding will be coded as a binary outcome: "yes" = correct; "no" and "I don't know" = incorrect.

Interventions

  • BEHAVIORAL UPF Warning Labels
  • BEHAVIORAL No Labels (Control)

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-12-01
Est. Completion 2025-12-20
Phase NA
University of Tennessee

96 total trials

What is known before NCT07227519 opens enrollment

NCT07227519 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).

The record links to 0 conditions, and to 2 interventions - of which UPF Warning Labels is the first listed.

NCT07227519 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07227519 about?

NCT07227519 is a clinical study titled "Effects of UPF Warning Labels on Social Media Among Teens and Young Adults". This study aims to evaluate whether Ultra-Processed Food (UPF) warning labels on social media posts improve consumer understanding and influence purchase intentions among teens and young adults. Participants aged 13-29 in the United States will be recruited and randomized into two groups: a control ...

What is the current status of trial NCT07227519?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-12-01. Estimated completion is 2025-12-20.

What interventions are being tested in trial NCT07227519?

The interventions under investigation include: UPF Warning Labels (BEHAVIORAL), No Labels (Control) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07227519?

This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07227519's enrollment target sits among peer trials

1,000 107th of 2000 higher than 1,880 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07227519, the US trial registry maintained by the National Library of Medicine. NCT07227519 (large enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.